Navigation Links
Biomarkers and Innovation Push Global Cancer Diagnostics Market Toward $8 Billion
Date:3/12/2008

NEW YORK, March 12 /PRNewswire/ -- The world market for in vitro diagnostic (IVD) tests for cancer is growing at nearly 11% annually and could reach nearly $8 billion by the end of 2012, according to a new study released today by Kalorama Information. In addition to demographic and epidemiologic shifts, the cancer testing market is being driven by a number of advances in traditional technologies, biomarker development, and new clinical priorities.

According to the study, The Worldwide Market for Cancer Diagnostics, 3rd Edition, the increased level of cancer screening, a public health priority as well as a healthcare cost priority, continues to drive some basic testing techniques such as fecal occult blood testing. However, advances in pharmacodiagnostic technologies aimed at refining treatment options and genetic and molecular tests to determine tumor growth pathways in the evaluation of patients at risk are creating exciting opportunities for research development and offer the potential to open new market niches.

In addition to technology, the report notes that the emergence of the new paradigm that views cancer as a chronic disease has also been a boon for IVD developers. With advances in early screening and improved therapeutics, there is more need for cancer management and monitoring tests.

"One of the most exciting aspects of the current cancer diagnostics market is the high level of collaboration we're seeing among complementary technologies," notes Shara Rosen, the author of the report. "New products will be made up of a mix of component parts from different platform companies, information technology providers, and reagent companies."

Kalorama Information's report The Worldwide Market for Cancer Diagnostics, 3rd Edition includes market size and growth forecasts to 2012; market segmentations by cancer type, IVD discipline, and geography; extensive discussions of technology development and penetration; and profiles of over 150 companies active in the segment. The report can be purchased directly from Kalorama Information by visiting http://www.kaloramainformation.com/Worldwide-Cancer-Diagnostics-1393082/.

About Kalorama Information

Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. For more information, contact Andrea Hiller at 212-807-2673 or press@kaloramainformation.com, or visit http://www.kaloramaInformation.com.


'/>"/>
SOURCE Kalorama Information
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Biomarkers for Mood May Alter Psychiatric Treatments
2. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
3. Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer
4. New developments in biomarkers for epithelial ovarian cancer
5. Biomarkers for Alzheimers disease can be trusted in clinical trials
6. JDRF and Lilly partner to fund research to identify beta cell biomarkers
7. Biomarkers predict risk for invasive breast cancer years before the tumor develops
8. Study makes progress in zoning in on biomarkers for better colon cancer treatment
9. Penn School of Medicine receives $2.3 million to study biomarkers of cigarette smoke exposure
10. Pharos Innovations Announces First Recipient of National Award for Achievements in Chronic Care Programs and Research
11. Surgery looks at inventions and innovations by surgeons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... Dr. Poneh Ghasri, cosmetic ... treatments to both new and existing patients. Cosmetic dentistry allows patients to improve the ... have healthy smiles with some minor or more serious cosmetic flaws. These specials allow ...
(Date:5/3/2016)... ... May 03, 2016 , ... Celestix ... announced the new SecureAccess feature for its CelestixEdge solution. CelestixEdge is the ... enable organizations to get the DirectAccess user experience on unsupported DirectAccess clients ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... helps healthcare organizations, especially medium and small physician practices, to better grasp and ... unique step-by-step approach that guides practices on a well-defined, expert-created path to compliance. ...
(Date:5/2/2016)... ... May 03, 2016 , ... RNK Products, Inc. (RNK) ... software that enables the stethoscope stream to go over the video conferencing audio ... flagship PCP-USB stethoscope. , Remote auscultation involves two software elements on the PC: ...
(Date:5/2/2016)... ... May 02, 2016 , ... The ... Patient Experience Journal (PXJ), an international, open access, peer-reviewed journal focused on research ... issue representing international (non-US) based authors, the third volume of PXJ continues to ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... NEW YORK , May 2, 2016 ... the EMR (Electronic Medical Records) market in a recent ... International sales, vendor switches, Increased physician usage, a growing market ... trends were noted in Kalorama,s report EMR ... The report marks Kalorama,s seventh complete study of the ...
(Date:5/2/2016)...  Celsion Corporation (NASDAQ: CLSN ), an ... the first cohort of patients in its Phase ... combining GEN-1, the Company,s DNA-based immunotherapy, with the ... patients with advanced ovarian cancer who will undergo ... the first three patients dosed, GEN-1 plus standard ...
(Date:4/29/2016)... April 29, 2016 Acquisition ... Sciences, Product Development Capabilities in North ... Base . Indegene ( http://www.indegene.com ... the acquisition of Skura Corporation,s life science business. ... adaptive sales enablement technology for life science organizations ...
Breaking Medicine Technology: